ABOUT
Who We Are
Our Team
The Toronto Advantage
Our Strategy
Our Success Stories
Policies
Awards
Careers
Accelerator Fund
For Researchers
UHN Community
Academic Partners
For Industry
Our Philosophy
UHN Opportunity
Collaborating With Researchers
Express Agreements
Mutual C/NDA
Resources
For Investors
New Ventures
Our Companies
Our New Venture Model
Resources
Licensing
Express Licenses
Clinical Tools
Available Technologies
News & Events
Contact
Archived news
This is some text inside of a div block.
-
Text Link
This is some text inside of a div block.
-
Text Link
This is some text inside of a div block.
-
Text Link
This is some text inside of a div block.
-
Text Link
September 3, 2026
-
From PhD Project to Global Impact: How a UHN Innovation is Transforming Spinal Cord Injury Rehabilitation
May 6, 2026
-
Welcome, Laurent Balenci!
February 20, 2026
-
Welcome, John McCulloch!
January 29, 2026
-
Celebrating UHN's 2025 Inventors of the Year
December 16, 2025
-
From Metal Pins to 3D Scans: How UHN’s Cone Beam CT innovation revolutionized brain treatment
September 30, 2025
-
New partnership aimed to improve care for patients with overlapping heart, kidney, and metabolic diseases
August 20, 2025
-
New Partnership Initiated to Commercialize UHN Heart Failure Care Technology
April 11, 2025
-
Dr. Daniel De Carvalho wins 2025 Gairdner Momentum Award for advancing cancer detection.
March 21, 2025
-
Drs. Jean Wang, John Dick and Jayne Danska win 2024 Inventor of the Year Award!
November 8, 2024
-
UHNLeashed: Inaugural Commercialization & Partnering Showcase
October 3, 2024
-
Newest study further validates sensitivity of cancer detection test
September 12, 2024
-
Welcome, Steve Schudlo!
August 27, 2024
-
Accelerator Fund Announces Inaugural Recipients
May 8, 2024
-
The Future of Canada’s Economy Will Be Research-Based
May 6, 2024
-
Accelerator Fund for Commercialization Launches at UHN
December 5, 2023
-
Dr. Frances Chung named UHN Inventor of the Year
September 25, 2023
-
Adela announces next financing round
July 14, 2023
-
Newly launched UHN company Nanogenix will use nanotechnology to target pancreatic and skin cancers
June 5, 2023
-
UHN partners with Providence Therapeutics
April 24, 2023
-
Improving Radiation Therapy
April 19, 2023
-
Adela’s multi-cancer blood test shows promise in detecting early stage tumors (AACR)
April 11, 2023
-
Welcome, Robert Foldes!
March 20, 2023
-
Honouring Extraordinary Achievement
February 24, 2022
-
Another UHN Start-Up Goes Public!
March 22, 2022
-
Discovery behind blockbuster Pfizer-Trillium deal started at UHN and SickKids
April 8, 2022
-
Accelerating Technology in Health
April 19, 2022
-
Welcome, Erno Wienholds!
May 10, 2022
-
Welcome, Allan DeBono!
May 31, 2022
-
Welcome, Laura McLachlan!
June 15, 2022
-
Banding together for pandemic research
June 22, 2022
-
UHN launches start-up to advance blood-based precision medicine
November 17, 2022
-
The hottest private biotech companies in Canada
December 12, 2022
-
UHN Inventor of the Year
March 3, 2021
-
World-first: Pilot study treating Fabry disease with gene therapy receives promising results
April 23, 2021
-
From discovery to drug development on home turf
April 27, 2021
-
Jump-starting memory with DBS
June 22, 2021
-
UHN launches start-up to advance blood-based precision medicine
July 8, 2021
-
The Ontario government awards UHN over $3.8 million for cutting-edge research
September 22, 2021
-
Lucid Psycheceuticals Acquired by FSD Pharma to further develop UHN MS therapy platform
November 1, 2021
-
University Health Network reported top Canadian research commercialization institution for 2nd year running
November 18, 2021
-
Treadwell Therapeutics' Series B set to fund clinical development of UHN's cancer fighting assets.
December 1, 2021
-
Krembil's annual report features commercialization partnership
Back to News
